MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer

Table 1

Patient characteristics (N = 37).

Age
Median	59
Range	36–82
	N	%
Gender
Men	27	73
Women	10	27
Performance status
0	33	89
1	3	8
2	1	3
Primary site
Oral cavity	12	32
Larynx	11	30
Oropharynx	8	22
Hypopharynx	4	11
Paranasal Sinuses	1	3
Major Salivary Glands	1	3
Stage
II	2	5
III	6	16
IV	29	78